<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01264809</url>
  </required_header>
  <id_info>
    <org_study_id>09/B/07</org_study_id>
    <secondary_id>2010-A00450-39</secondary_id>
    <nct_id>NCT01264809</nct_id>
  </id_info>
  <brief_title>Exercise Consultation for Type 2 Diabetes Patients in Real Life</brief_title>
  <acronym>APDT 2</acronym>
  <official_title>Does Exercise Consultation Have a Realistic Chance of Increasing the Physical Activity Level of Type 2 Diabetes Patients in Real Life?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Center of Martinique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinique Antilles-Guyane</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Center of Martinique</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of type 2 diabetes is high and expected to increase dramatically in worldwide,
      in France and especially in the French West Indies.This chronic disease is associated with
      premature mortality and various debilitating complications which can be prevented by optimal
      control of glycaemia, blood pressure and lipids. Diabetes management includes lifestyle
      modification and medication. Despite numerous studies supporting the benefits of frequent
      physical activity for people with Type 2 diabetes, an estimated 60±80% of this population
      remain sedentary. Promotion of physical activity in current diabetes care seems to be
      inadequate.

      The aim of this randomized controlled trial is to evaluate the medium-term effectiveness
      (after 3 and 6months) of exercise consultation in promoting physical activity in outpatients
      with Type 2 diabetes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in daily physical activity measured by SenseWear Pro3 Armband®. Participants were instructed to wear the monitor for seven days during all waking hours except bathing.</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Benefits obtained after the physical activity counseling</measure>
    <time_frame>6 months</time_frame>
    <description>The secondary outcome of this study is to compare the benefits obtained 3 and 6 mounths after the physical activity counseling on :
Quality of life scores
Anthropometric measurement and Body Mass Index (BMI)
Body composition measurement
Hand grip strength
Blood pressure
Glycaemic control and cholesterol
Medication</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>A : immediate physical activity counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants randomized in the experimental group (group A) will receive physical activity counseling during a one-to-one consultation at both baseline and 3 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B : later physical activity counseling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exercise consultation will be realised only at 3 months in the control group(group B). Furthermore, patients of group B will not received any physical activity counseling at baseline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Specific consultation for physical activity counseling</intervention_name>
    <description>Specific consultation</description>
    <arm_group_label>A : immediate physical activity counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Consultation for physical activity counseling</intervention_name>
    <description>Specific consultation</description>
    <arm_group_label>B : later physical activity counseling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 DM diagnosed within 10 years prior the inclusion

          -  18-70 years old

          -  Signed written informed consent

          -  Diabetes treatment regimens :

               -  diet only

               -  oral antidiabetic drug

               -  oral antidiabetic drugs with long acting insulin analog

               -  oral antidiabetic drugs with GLP 1 analog

        Exclusion Criteria:

          -  Minors

          -  Patients with concurrent medical conditions preventing exercise

          -  Pregnancy or intention to become pregnant during the study

          -  Inability to read and write French

          -  History of participating in our education program during the past two years

          -  Usual sporty activities

          -  Change in diabetes treatment during the three months prior to study enrollment

          -  No written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cédric FAGOUR, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Fort-de-France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jocelyne CRASPAG</last_name>
    <phone>(0)596592698</phone>
    <phone_ext>+596</phone_ext>
    <email>jocelyne.craspag@chu-fortdefrance.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mickaëlle ROSE</last_name>
    <phone>(0) 596592698</phone>
    <phone_ext>+596</phone_ext>
    <email>mickaelle.rose@chu-fortdefrance.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Fort-de-France- Hôpital Pierre Zobda Quitman</name>
      <address>
        <city>Fort-de-France</city>
        <state>Martinique</state>
        <zip>97261</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cédric FAGOUR, MD</last_name>
      <phone>(0)596552241</phone>
      <phone_ext>+596</phone_ext>
      <email>cedric.fagour@chu-fortdefrance.fr</email>
    </contact>
    <contact_backup>
      <last_name>Miguelle ROSETTE-NARECE, MD</last_name>
      <phone>(0)596552241</phone>
      <phone_ext>+596</phone_ext>
      <email>miguelle.rosette-narece@chu-fortdefrance.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Cedric FAGOUR, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguelle ROSETTE-NARECE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Bordeaux - Hôpital Haut Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent RIGALLEAU, MD-PhD</last_name>
      <phone>(0)556795679</phone>
      <phone_ext>+33</phone_ext>
      <email>vincent.rigalleau@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Henri GIN, MD-PhD</last_name>
      <phone>(0)556795679</phone>
      <phone_ext>+33</phone_ext>
      <email>henri.gin@chu-bordeaux.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Vincent RIGALLEAU, MD-PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Henri GIN, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2010</study_first_submitted>
  <study_first_submitted_qc>December 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2010</study_first_posted>
  <last_update_submitted>December 21, 2010</last_update_submitted>
  <last_update_submitted_qc>December 21, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>FAGOUR Cédric</name_title>
    <organization>CHU de Fort-de-France</organization>
  </responsible_party>
  <keyword>diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

